PHARMACOKINETICS OF ATAZANAVIR IN RITONAVIR-BOOSTED COMBINATION IN ASIAN HEALTHY VOLUNTEERS: COMPARISONS BETWEEN THE STANDARD AND REDUCED DOSES OF BOTH AGENTS

Atazanavir/ritonavir (ATV/r) 200/100 mg once-daily (OD) has been shown comparable in drug exposure to the standard dose in Asian study. We explored the pharmacokinetic profiles of the boosting effect of..

[1]  U. Fuhr,et al.  Do activities of cytochrome P450 (CYP)3A, CYP2D6 and P-glycoprotein differ between healthy volunteers and HIV-infected patients? , 2010, Antiviral therapy.

[2]  B. Clotet,et al.  Monitoring Atazanavir Concentrations With Boosted or Unboosted Regimens in HIV-Infected Patients in Routine Clinical Practice , 2007, Therapeutic drug monitoring.

[3]  T. Kakuda,et al.  7th International Workshop on Clinical Pharmacology of HIV Therapy , 2006, Expert opinion on pharmacotherapy.

[4]  高橋 聡,et al.  Common Terminology Criteria for Adverse Events (CTCAE) v3.0による胃癌術後合併症の解析 , 2006 .

[5]  K. Ruxrungtham,et al.  Pharmacokinetics of Reduced-Dose Indinavir/Ritonavir 400/100 Mg Twice Daily in HIV-1-Infected Thai Patients , 2005, Antiviral therapy.

[6]  P. Anderson,et al.  6th International Workshop on Clinical Pharmacology of HIV Therapy , 2004, Expert opinion on pharmacotherapy.

[7]  Sean Emery,et al.  HIV medicine , 2002, The Medical journal of Australia.

[8]  M. Saag,et al.  Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults , 2000, Antimicrobial Agents and Chemotherapy.

[9]  J. Leonard,et al.  Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy Volunteers , 1998, Antimicrobial Agents and Chemotherapy.

[10]  Isma'il ibn Ali al-Sadiq.  AIDS , 1986, The Lancet.

[11]  W. Bretz,et al.  Red Marine Algae Lithothamnion calcareum Supports Dental Enamel Mineralization , 2023, Marine drugs.

[12]  A. Rachlis,et al.  Antiviral therapy. , 1989, Clinics in dermatology.